Collegium Pharmaceutical: Q2 Earnings Snapshot

In this article:

STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported second-quarter profit of $13 million.

On a per-share basis, the Stoughton, Massachusetts-based company said it had net income of 34 cents. Earnings, adjusted for one-time gains and costs, were $1.26 per share.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.22 per share.

The specialty pharmaceutical company posted revenue of $135.5 million in the period, which missed Street forecasts. Five analysts surveyed by Zacks expected $138 million.

Collegium Pharmaceutical expects full-year revenue in the range of $565 million to $580 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL

Advertisement